Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.61B |
| 2 |
Microsoft
MSFT
|
+$1.17B |
| 3 |
Broadcom
AVGO
|
+$366M |
| 4 |
Merck
MRK
|
+$343M |
| 5 |
Meta Platforms (Facebook)
META
|
+$260M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$609M |
| 2 |
CMA
Comerica
CMA
|
+$512M |
| 3 |
CADE
Cadence Bank
CADE
|
+$422M |
| 4 |
Johnson & Johnson
JNJ
|
+$331M |
| 5 |
Western Digital
WDC
|
+$277M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.81% |
| 2 | Financials | 17.07% |
| 3 | Industrials | 12.54% |
| 4 | Consumer Discretionary | 10.14% |
| 5 | Healthcare | 9.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SRG
3101
Seritage Growth Properties
SRG
$130M
| $123K | ﹤0.01% |
44,120
+3,502
| +9% | +$10.9K |
|
3102
Century Therapeutics
IPSC
$381M
| $122K | ﹤0.01% |
+55,183
| New | +$116K |
|
3103
Prelude Therapeutics
PRLD
$305M
| $120K | ﹤0.01% |
+35,210
| New | +$92.3K |
|
3104
AYTU BioPharma
AYTU
$23.2M
| $119K | ﹤0.01% |
43,585
+8,222
| +23% | +$21K |
|
3105
Vince Holding Corp
VNCE
$76.2M
| $117K | ﹤0.01% |
48,399
+15,266
| +46% | +$41.9K |
|
3106
Accuray
ARAY
$28.4M
| $114K | ﹤0.01% |
294,903
-60
| -0% | -$37 |
|
|
WBTN
3107
WEBTOON Entertainment Inc
WBTN
$1.22B
| $114K | ﹤0.01% |
12,420
-3,624
| -23% | -$40.7K |
|
3108
NIO
NIO
$11.3B
| $113K | ﹤0.01% |
18,726
-73,391
| -80% | -$371K |
|
|
TOUR
3109
Tuniu
TOUR
$55.4M
| $112K | ﹤0.01% |
14,502
| – | – |
|
3110
Broadway Financial
BYFC
$94.9M
| $112K | ﹤0.01% |
15,387
-1,267
| -8% | -$10.2K |
|
|
NTSK
3111
Netskope Inc
NTSK
$4.66B
| $111K | ﹤0.01% |
+13,054
| New | +$162K |
|
3112
The Beachbody Company
BODI
$78.9M
| $111K | ﹤0.01% |
+10,193
| New | +$102K |
|
|
WHWK
3113
Whitehawk Therapeutics
WHWK
$183M
| $104K | ﹤0.01% |
30,090
+1,449
| +5% | +$4.54K |
|
3114
RAVE Restaurant Group
RAVE
$44.5M
| $104K | ﹤0.01% |
39,095
+2,991
| +8% | +$8.96K |
|
3115
Air Industries Group
AIRI
$13.2M
| $104K | ﹤0.01% |
32,053
+4,051
| +14% | +$13.3K |
|
3116
Immuneering
IMRX
$279M
| $103K | ﹤0.01% |
19,562
| – | – |
|
3117
Marchex
MCHX
$79.7M
| $103K | ﹤0.01% |
66,276
| – | – |
|
3118
Red Robin
RRGB
$134M
| $102K | ﹤0.01% |
35,015
+13,929
| +66% | +$52.3K |
|
3119
Rallybio
RLYB
$86.6M
| $101K | ﹤0.01% |
+11,280
| New | +$77.1K |
|
|
TMQ
3120
Trilogy Metals
TMQ
$522M
| $98.8K | ﹤0.01% |
27,514
| – | – |
|
3121
Harte-Hanks
HHS
$17.7M
| $96.8K | ﹤0.01% |
42,621
-3,367
| -7% | -$9.56K |
|
|
STKL
3122
DELISTED
SunOpta
STKL
| $96.5K | ﹤0.01% |
14,891
-177,912
| -92% | -$1.01M |
|
3123
Novavax
NVAX
$1.23B
| $96.4K | ﹤0.01% |
11,847
+689
| +6% | +$6.25K |
|
3124
First Guaranty Bancshares
FGBI
$153M
| $93.7K | ﹤0.01% |
11,556
-425
| -4% | -$3.58K |
|
3125
The ONE Group
STKS
$57.1M
| $93.6K | ﹤0.01% |
52,612
| – | – |
|
Similar funds
Dimensional Fund Advisors's Q1 2026 Portfolio in Review
As of Q1 2026, Dimensional Fund Advisors held 3,312 positions worth $481B, up 0.98% from $477B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Dimensional Fund Advisors's Q1 2026 filing shows 72 new, 1,935 increased, 1,135 reduced and 97 closed positions. Its largest new stake was Versant Media Group: 1,127,961 shares worth $41.7M. The largest sale was AstraZeneca, an estimated $609M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Financials and Industrials.
- Dimensional Fund Advisors's largest Q1 2026 buy was Versant Media Group: 1,127,961 shares worth $41.7M.
- Dimensional Fund Advisors added most to Amazon in Q1 2026, an estimated $1.61B increase.
- Dimensional Fund Advisors's biggest Q1 2026 reduction was Johnson & Johnson, cutting an estimated $331M.
- Dimensional Fund Advisors fully exited AstraZeneca in Q1 2026, selling an estimated $609M.
- Dimensional Fund Advisors's ten largest holdings make up 17% of its $481B portfolio in Q1 2026.
- Dimensional Fund Advisors opened 72 new positions and closed 97 in Q1 2026.
- Dimensional Fund Advisors's portfolio value rose 0.98% quarter-over-quarter to $481B.
Based on Dimensional Fund Advisors's 13F filing for Q1 2026, filed 7 May 2026.